Navigation Links
New lab mice cut search for genetic links to disease by more than a decade
Date:4/5/2012

With a 95 percent genomic similarity to humans, mice have long been used to learn about the genetic causes of human disease. Once researchers can shine a light on the genetic factors that cause disease in mice, they can start to develop prevention and treatment options to protect the human population.

But this process, called genetic mapping, is a long and difficult road, made more challenging by the 5% difference between the humans and lab mice. Now Prof. Fuad Iraqi of Tel Aviv University's Sackler Faculty of Medicine is closing the gap with an international project called Collaborative Cross. The project is developing lab mice with increased genetic diversity, making them more advantageous for genetic research related to human health.

The new population will offer 1,000 genetic strains within a fixed genotype the composite of the entire genetic makeup of an organism. This is a marked improvement on the previously existing 450 genetic strains of lab mice with varying genotypes, making Prof. Iraqi's new strain ideal for genetic mapping. And with these mice, researchers will be able to identify a gene associated with a particular disease within two to three years instead of the 10 to 15 years it takes now, says Prof. Iraqi.

The research has been published in the journals Nature, Nature Genetics, and Genome Research, and receives its primary funding from the Wellcome Trust in the UK. The project itself is a collaboration among Tel Aviv University, Oxford University in the UK, North Carolina State University in the US, and Perth University in Australia.

Expanding the family tree

Genetic determinants play an important role in a variety of conditions from diabetes and obesity to different types of cancers. For example, mutated forms of the genes BRCA1 and BRCA2, which can be genetically inherited, are associated with higher rates of breast and ovarian cancers. This kind of genetic diversi
'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Minneapolis Heart Institute selected to participate in Cardiovascular Cell Therapy Research Network
2. Improving equine health: Research studies vaccinations to protect newborn foals
3. Stomata development in plants unraveled -- a valuable discovery for environmental research
4. Incisive research links teeth with diet
5. SFU HIV/AIDS vaccine research gets financial boost
6. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
7. Plant research reveals new role for gene silencing protein
8. Tales from the crypt lead researchers to cancer discovery
9. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
10. Researcher who identifed genetic cause and possible treatment for Marfan syndrome honored
11. EU project: Searching for exotics in the shrimp nets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2015)... LOS ANGELES , March 23, 2015  In ... in Federal fraud case conviction losses. This figure accounts ... fraud, which, according to The Nilson Report, exceeds $11 ... an investigative tool after a crime has occurred. Investor ... Agent and polygraph expert Joe Paolella partnered ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Iris Biometrics - Global Strategic Business Report" report ... markets for Iris Biometrics in US$ Thousands. The report provides ... , Japan , Europe ... , and Latin America . ...
(Date:3/17/2015)...  MecklerMedia Corporation (OTCQX: MECK) announced its ... ever held in New York City ... 2015 at the Javits Convention Center. ... Acorn Product Development; Axis NJ; c-Link Systems; CoroWare; ... NewBotic Corporation; Neya Systems LLC; Reliabotics; RoboKind; RocketFarm ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... December 8, 2010 -- University of Miami (UM) graduate student ... with a Suncoast Emmy for her work on the Changing ... associate producer for the WPBT2 show, produced by Alexa Elliott, ... award is about legacy contaminants and other pollutants that people ...
... For contributions to bioinformatics and computer systems security, ... the University of California, San Diego are among 41 ... and Savage are from the Department of Computer Science ... School of Engineering. The ACM, or Association for ...
... Dec. 8, 2010 Reportlinker.com announces that ... in its catalogue: Personalized ... and Proteomics to Challenge Traditional Therapeutics ... Personalized Medicine Market - Advances in Human ...
Cached Biology News:University of Miami marine biology student wins Emmy Award for work on 'Changing Seas' 2UC San Diego computer scientists lauded for computer systems security, bioinformatics work 2UC San Diego computer scientists lauded for computer systems security, bioinformatics work 3Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 2Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 3Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 4Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 5Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 6Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 7Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 8Reportlinker Adds Personalized Medicine Market - Advances in Human Genomics and Proteomics to Challenge Traditional Therapeutics 9
(Date:3/30/2015)... 2015 CASI Pharmaceuticals, Inc. (Nasdaq: CASI ... and commercialization of innovative therapeutics addressing cancer and other ... commercial focus on China , announced ... has approved the Company,s application to conduct a Phase ... (OCCC) patients for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... CARDIFF, UK, and BELLINGHAM, Washington, USA (PRWEB) March 29, ... energy projects in Europe and the United States and ... programme highlights planned for SPIE Optics + Optoelectronics ... will feature over 700 technical presentations in 17 conferences ... international society for optics and photonics , the event ...
(Date:3/30/2015)... MADISON, Wis. , March 30, 2015  FUJIFILM ... ("Fujifilm") and Cellular Dynamics International, Inc. (CEO: Robert ... leading developer and manufacturer of fully functioning human cells ... the two companies have entered into a definitive agreement ... offer to be followed by a second step merger. ...
(Date:3/29/2015)... March 29, 2015 As a symbol ... required by our pharmaceutical manufacturing clients, Whitehouse Laboratories is ... of the Berkenstock Race Team for the 2015 race ... only speed, but a strong sense of precision and ... lead to success in the quality control testing laboratory. ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 2Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 3Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 4Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 5Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 6Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 7Fujifilm Holdings to Acquire Cellular Dynamics International, Inc. 8Whitehouse Laboratories Reaffirms Commitment to Speedy Results – Renews Sponsorship of Berkenstock Racing Team 2
... University of Maryland researchers have discovered a way to control ... applications in magnetic storage and magnetic random access memory. ... Physics Professor Michael S. Fuhrer of the UMD Center for ... properties discovered for graphene. A honeycomb sheet of carbon ...
... ATLANTA and IRVINE, Calif., April 15, 2011 CryoLife, ... medical device and cardiovascular tissue processing company, today announced ... proposed acquisition of Cardiogenesis Corporation ("Cardiogenesis") to acquire only ... On April 14, 2011, Cardiogenesis, CryoLife and ...
... April 15, 2011 ClearCanvas Inc., an innovative ... release of their clinical radiology workstation product, ClearCanvas ... ClearCanvas has offered a commercial version of their ... an open source application. ClearCanvas open ...
Cached Biology Technology:UMD scientists make magnetic new graphene discovery 2CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation 2CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation 3CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation 4CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation 5CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation 6CryoLife Amends Tender Offer Related to its Proposed Acquisition of Cardiogenesis Corporation 7ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow 2